《中国康复理论与实践》

《中国康复理论与实践》 ›› 2007, Vol. 13 ›› Issue (03): 222-224.

• 专题 脑梗死康复 • 上一篇    下一篇

急性脑梗死静脉溶栓治疗的难点与对策

方晓磊; 刘金民; 江涛   

  1. 北京中医药大学东方医院急诊科,北京市 100078
  • 收稿日期:2007-02-06 出版日期:2007-03-01 发布日期:2007-03-01

Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction

FANG Xiao-lei, LIU Jin-min, JIANG Tao   

  1. Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100078, China
  • Received:2007-02-06 Published:2007-03-01 Online:2007-03-01

PDF (PC)

摘要： 本文指出按照国际指南以重组组织型纤溶酶原激活剂(r-tPA)进行规范静脉溶栓治疗急性脑梗死的重要性;提出了临床实践中常见的5方面问题:接受溶栓治疗的急性脑梗死患者较少、r-tPA的价格限制了临床应用、中国人r-tPA用量尚待摸索、溶栓疗效不理想以及中医药参与溶栓治疗有限,并对每一问题提出应对措施。对中医药干预超早期脑梗死溶栓治疗提出自己的想法。

关键词: 急性脑梗死, 经静脉溶栓, 重组组织型纤溶酶原激活剂(r-tPA), 中医药

Abstract: This paper points out the importance of intravenous thrombolysis with recombinant tissue plasminogen activator(r-tPA)according to the international guidelines in acute ischemic stroke.Some practical problems,such as the lower rate of thrombolysis for ischemic stroke,the price of r-tPA being too expensive to clinical using,the dosage of r-tPA in Chinese being not clear,the curative effect being not so good,and traditional Chinese medicine (TCM) applied in intravenous thrombolysis,and so on,should be further discussed.

Key words: acute cerebral infarction, intravenous thrombolysis, recombinant tissue plasminogen activator (r-tPA), traditional Chinese medicine (TCM)